The therapy did not resolve the clot on the right side, therefore this is a reportable event.Having the clot remain, increases the risk of further pulmonary events in this patient.Two levels of investigation was performed - microscopic and functional.A microscopic review revealed the presence of blood in the drug lumen.The returned complaint sample appeared to have been aspirated with a syringe from all ports.Moderate difficulty was encountered while flushing from the drug port during the functional evaluation.The ifu directs users against blood draw procedures through the drug lumen.The root cause of this event therefore appears to be use/user related.
|
Customer contacted the ekos helpline at the beginning of a bilateral pulmonary embolism (pe) case reporting an alarm on the right lung drug port pump.Hospital staff flushed the catheter using 4 x w/1cc syringe and the pump was restarted.After 10.5 hours the pump alarmed due to a downstream occlusion.Flushing was performed, with resistance noted.The pump pressure was increased to 'maximum' however the pump continued to alarm.The physician stopped the administration of the tissue plasminogen activator (tpa) to the right lung and continued the coolant through the catheter.Post cessation of the ekos therapy the physician attempted to extract the clot using penumbra, however no clot was aspirated.The physician deemed that the right lung clot was a 'chronic clot'(verbatim).The reporter stated that the patient 'did well' (verbatim) with therapy, with the left lung reported as 'mostly clear of clot'(verbatim).
|